跳至主要内容
临床试验/NCT07376772
NCT07376772招募中不适用

Feasibility, Preliminary Efficacy, and User Perspective Usability of Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

University of Florida2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2026年3月4日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
15
试验地点
2
主要终点
Nine-Hole Peg Test (9HPT)

研究概览

简要总结

This pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for improving upper extremity (UEx) function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS (PRMS) and self-reported UEx impairments will participate in a 4-week FVT program using MyovoltTM wearable FVT devices applied to arm muscles.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged over 18 years
  • Confirmed diagnosis of RRMS according to the McDonald criteria (33)
  • No MS relapse or exacerbation within the past 6 months (ensuring stability of symptoms)
  • Self-report on clinical evidence of UEx impairment (including reduced arm/hand function, muscle weakness, spasticity, or pain).
  • Stable on MS treatment for at least four weeks before recruitment, with no plans to initiate new treatments (participants may continue current treatments during the study)
  • Agree and are able to use the FVT device after training.
  • Sufficient proficiency in English to participate in interviews and follow instructions
  • Able to visit the laboratory for assessments
  • Able to provide written informed consent

排除标准

  • Evidence of cognitive impairment that could interfere with following instructions (Mini-Montreal Cognitive Assessment score (Mini-MoCA) < 12)
  • Comorbid neurological or psychiatric conditions affecting the UEx (including stroke and severe carpal tunnel syndrome) that would confound results or make FVT unsafe
  • Unstable cardiac disease or any major medical illness that would preclude participation
  • Any known contraindications to vibration therapy (pregnancy, acute deep vein thrombosis, severe osteoporosis, chronic migraines, epilepsy, active malignancy in the target area, unstable cardiac disease, or an implanted pacemaker without clearance)

研究组 & 干预措施

Intervention group

Experimental

Participants who will recieve the focal vibration therapy

干预措施: wearable focal vibration therapy (Device)

结局指标

主要结局

Nine-Hole Peg Test (9HPT)

时间窗: Baseline, week 4, week 8

The Nine-Hole Peg Test (9HPT) assesses fine motor coordination and dexterity by timing how quickly participants can place and remove nine pegs from a pegboard using one hand.

次要结局

  • Arm Function in Multiple Sclerosis Questionnaire (AMSQ)(Baseline, week 4, week 8)
  • Box and Block Test (BBT)(Baseline, week 4, week 8)
  • Muscle Strength(Baseline, week 4, week 8)
  • Modified Ashworth Scale (MAS)(Baseline, week 4, week 8)
  • Visual Analog Scale (VAS) of Pain(Baseline, week 4, week 8)
  • Modified Fatigue Impact Scale (MFIS)(Baseline, week 4, week 8)
  • Usability(week 4, week 8)
  • Adherence(week 4)
  • Retention rate(baseline, week 4, week 8)
  • Adverse events(week 4, week 8)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验